Respiratory Care Devices Market Research, 2033
The global respiratory care devices market size was valued at $22.9 billion in 2023, and is projected to reach $47.9 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033. Driving factors for the respiratory care devices market growth nclude the increasing prevalence of chronic respiratory diseases such as COPD and asthma, rising geriatric population prone to respiratory conditions, advancements in respiratory care technology, and the growing demand for home healthcare solutions
Market Introduction and Definition
Respiratory care devices encompass a diverse range of medical equipment designed to aid in the management and treatment of respiratory conditions and disorders. These devices serve various functions, including oxygen therapy, ventilation support, airway clearance, and monitoring of respiratory parameters. From simple devices such as oxygen masks and nasal cannulas to advanced ventilators and continuous positive airway pressure (CPAP) machines, respiratory care devices play a crucial role in delivering respiratory support to patients in clinical settings, home care environments, and during emergencies. By assisting in breathing, maintaining oxygen levels, and improving lung function, these devices help alleviate symptoms, enhance patient comfort, and optimize respiratory health outcomes.
Key Takeaways
- The respiratory care devices market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major respiratory care devices industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Segments
- By Product
- Therapeutic Devices
- Positive airway pressure (PAP) devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Bilevel PAP (BPAP) devices
- Automatic positive airway pressure (APAP) devices
- Mask
- Nasal masks
- Full-face masks
- Nasal pillow masks
- Oral masks
- Ventilators
- Adult ventilator
- Infant/neonatal ventilator
- Nebulizers
- Humidifiers
- Oxygen concentrators
- Fixed oxygen concentrators
- Portable oxygen concentrators
- Inhalers
- Reusable Resuscitators
- Nitric oxide delivery units
- Capnographs
- Gas analyzers
- Oxygen hoods
- Monitoring Devices
- Pulse oximeters
- Pediatric pulse oximeters
- Wrist-worn pulse oximeters
- Hand-held pulse oximeters
- Fingertip pulse oximeters
- Table-top/bedside pulse oximeters
- Diagnostic Devices
- Spirometers
- Polysomnography (PSG) devices
- Peak flow meters
- Consumables and Accessories
- Disposable masks
- Disposable resuscitators
- Tracheostomy tubes
- Nasal cannulas
- Others
- By End User
- By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ResMed
- Invacare Corporation
- Chart Industries
- Drägerwerk AG & Co. KGaA
- Becton, Dickinson and Company
- Fisher & Paykel Healthcare Limited.
- Masimo
- Hamilton Medical
- Koninklijke Philips N.V.
- Medtronic